News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Bellinger Andrew
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/16/2022 |
4
| Bellinger Andrew (CSO & CMO) has filed a Form 4 on Verve Therapeutics, Inc.|
Txns:
| Exercised 36,000 options to buy
@ $2.87, valued at
$103.3k
|
|
| 12/02/2022 |
4
| Bellinger Andrew (CSO & CMO) has filed a Form 4 on Verve Therapeutics, Inc.|
Txns:
| Sold 865 shares
@ $22.95, valued at
$19.9k
|
|
| 09/27/2022 |
4
| Bellinger Andrew (CSO & CMO) has filed a Form 4 on Verve Therapeutics, Inc.|
Txns:
| Sold 6,632 shares
@ $34.666, valued at
$229.9k
Sold 13,368 shares
@ $35.5927, valued at
$475.8k
Sold 36,798 shares
@ $35.3091, valued at
$1.3M
Sold 3,202 shares
@ $36.0336, valued at
$115.4k
Exercised 40,000 options to buy
@ $1.48, valued at
$59.2k
Exercised 20,000 options to buy
@ $1.48, valued at
$29.6k
|
|
| 07/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/15/2022 |
4
| Bellinger Andrew (Chief Scientific Officer) has filed a Form 4 on Verve Therapeutics, Inc.|
Txns:
| Granted 125,000 options to buy
@ $30.94, valued at
$3.9M
|
|
| 12/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|